Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial
Idorsia Pharmaceuticals Ltd.
Markus P Schlaich; Marc Bellet; Michael A Weber; Parisa Danaietash; George L Bakris; John M Flack; Roland F Dreier; Mouna Sassi-Sayadi; Lloyd P Haskell; Krzysztof Narkiewicz; Ji-Guang Wang; PRECISION investigators
Department of Biometry, Idorsia Pharmaceuticals, Allschwil, Switzerland.